Insider trades

Stephen Basil Thomas, Director of Climb Bio CLYM, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $879K. The latest trade was on 06/05.

Stephen Basil Thomas

Director
First filing
24/06/27
Trades
15 trades
Buys / sales
0 / 4
12-month net buying
−$879K
Last trade
06/05

Trading activity

Transactions

Trade type
CLYM
Open-market sale10b5-1 plan02/25–02/2602/2750,000 sh2 trades$7.00avg.$350,163.13−24.4%
CLYM
Open-market sale10b5-1 plan02/12–02/1302/17100,000 sh2 trades$5.29avg.$528,800−32.8%